bg
A

Aeglea Biotherapeutics (AGLE)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Aeglea Biotherapeutics (AGLE)

Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its lead product candidate is pegzilarginase, which is a recombinant human arginase 1 tha... Read more

  • USD11.34
  • USD12.31
  • USD11.01
  • USD39.00
  • -11.10%
  • 1M
  • 14.48k
  • 50.25k
  • 48M
  • 2.66
  • 5.40%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.